tirzepatide surpass-4 The Association Between Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4 Hush Medical Spa

This dual-action approach helps individuals lose weight and maintain their results over time

Now supporting the GLP-1 era

Improved treatment adherence : Remembering one or two injections per week proves easier than daily dosing

Semaglutide is recommended for individuals with a BMI of 27 or greater who have at least one weight-related health condition, such as high blood pressure or type 2 diabetes

Advantage : Neither (tie) Type 2 Diabetes Efficacy# CagriSema : REDEFINE 2 showed 13.7% weight loss and 73.5% of T2D patients achieving HbA1c of 6.5% or less at 68 weeks

To minimize discomfort, patients should eat smaller, more frequent meals, avoid high-fat and spicy foods, stay well-hydrated, and avoid lying down immediately after eating